Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What total market size is anticipated for the Tissue Heart Valves Market in 2030?
The tissue heart valves market has seen a consistent increase in its size over recent years. Projections indicate it will expand from $1.52 billion in 2025 to reach $1.56 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 2.6%. Historically, this growth can be ascribed to a rise in cardiovascular diseases, the limitations associated with mechanical valves, the increasing adoption of surgical valve replacement, advancements in hospital cardiac infrastructure, and the prevalence of aging demographics.
The tissue heart valves market is projected to experience consistent expansion in the coming years. Its valuation is anticipated to reach $1.72 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 2.5%. Factors contributing to this growth during the projected timeframe include the increasing adoption of TAVR procedures, the rise in minimally invasive cardiac surgeries, advancements in valve durability, improved access to healthcare, and the development of cardiology specialization. Key trends identified for this period encompass a growing preference for bioprosthetic valves, an increase in transcatheter valve procedures, enhanced tissue preservation methods, a decrease in the need for long-term anticoagulation, and the demand for valve replacements driven by an aging population.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21302&type=smp
What Drivers Are Influencing Production Trends In The Tissue Heart Valves Market?
The expanding occurrence of cardiovascular diseases is anticipated to boost the growth of the tissue heart valves market in the future. Cardiovascular diseases (CVDs) encompass a range of conditions impacting the heart and blood vessels, such as heart attacks, strokes, and high blood pressure. The rising incidence of CVDs stems mainly from elements like unhealthy living habits, an aging demographic, a greater presence of risk factors, inadequate diets, a lack of physical activity, smoking, stress, and urban development, all contributing to elevated rates of cardiac conditions worldwide. Tissue heart valves play a vital role in managing CVDs, offering a biocompatible, robust, and less clot-forming alternative for individuals needing valve replacement, thereby enhancing sustained heart function and lowering complication risks. For example, a report from September 2024, released by the Heart Failure Society of America (HFSA), a US-based professional entity, revealed that roughly 6.7 million Americans aged 20 and older are currently experiencing heart failure (HF). This figure is projected to climb to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. Consequently, the growing occurrence of cardiovascular diseases is a key driver for the expansion of the tissue heart valve market.
Which Segment Groups Are Influencing The Tissue Heart Valves Market?
The tissue heart valves market covered in this report is segmented –
1) By Type: Stented Tissue Heart Valves, Stentless Tissue Heart Valves
2) By Procedure Type: Surgical Aortic Valve Replacement (SAVR), Transcatheter Aortic Valve Replacement (TAVR)
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Stented Tissue Heart Valves: Bovine Pericardial Valves, Porcine Valves
2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves, Homograft Valves
What Upcoming Trends Are Likely To Define The Future Path Of The Tissue Heart Valves Market?
Leading firms within the tissue heart valves market are concentrating on creating advanced products, like surgical aortic tissue valves, aimed at simplifying implantation and lifelong patient care. This type of valve is a prosthetic heart valve, constructed from biological tissue, generally employed to substitute a diseased or compromised aortic valve during cardiac surgery. For example, in June 2024, Medtronic plc., an Ireland-based technology company, introduced the Avalus Ultra valve, a subsequent generation surgical aortic tissue valve conceived to improve user-friendliness during implantation and aid in prolonged patient management. Drawing on 10 years of clinical experience with the Avalus valve, this device incorporates a low valve profile, a polyetheretherketone (PEEK) base frame ensuring uniform circularity, and an industry-leading Effective Orifice Area (EOA) for enhanced blood flow. Furthermore, the valve incorporates a radiopaque coil, allowing clear visibility in subsequent valve-in-valve procedures, thus providing enduring durability for individuals suffering from aortic stenosis.
Who Are The Top-Performing Companies In The Tissue Heart Valves Market In Recent Years?
Major companies operating in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomédica, Anteris Technologies Ltd., Labcor Laboratórios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, St. Jude Medical Inc., Sorin Group, Hancock J & Co.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/tissue-heart-valves-global-market-report
How Does The Tissue Heart Valves Market Perform Across Major Global Regions?
North America was the largest region in the tissue heart valves market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue heart valves market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Tissue Heart Valves Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=21302&type=smp
Browse Through More Reports Similar to the Global Tissue Heart Valves Market 2026, By The Business Research Company
Prosthetic Heart Valve Devices And Equipment Global Market Report 2026
Pediatric Heart Valve Repair And Replacement Global Market Report 2026
Commercial Valves Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/commercial-valves-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company